Loading viewer...
conference
Format: PDF conference
Presentation delivered at the 41st Annual J.P. Morgan Healthcare Conference in January 2023. The company is advancing development programs across multiple therapeutic areas including Alzheimer's, Parkinson's, Migraine, and Hypercholesterolemia, with discussions of discovery, research activities, and anticipated clinical development timelines for product candidates.
investor_presentation
18 Pages
conference
27 Pages
Bristol Myers Squibb
Accelerate Diagnostics 2021 J.P. Morgan Healthcare Conference
conferenceconference
27 Pages
Accelerate Diagnostics, Inc.
Intercontinental Exchange ICE 2016 Conference Presentation
conferenceconference
13 Pages
Intercontinental Exchange